(CercleFinance.com) – Valneva announces that it will make presentations on its single-shot chikungunya vaccine candidate during the fourth quarter of 2022 at several leading scientific conferences.
The vaccine company will thus be present for this purpose at the World Vaccine Congress Europe in Barcelona (October 11 to 14), then at the ICTMM congress in Bangkok (October 27) and at the ASTMH annual meeting in Seattle (October 30 to October 3 november).
Valneva will also participate in the ISPOR European Congress, which will be held virtually from November 6 to 9 in Vienna, and will make a presentation at the JITMM which will take place from December 7 to 9 in Bangkok.